Clinical Trial Update: Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic Overweight or Obese Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, pharmacodynamics, safety and tolerability of the BGM0504 injection in non-diabetic overweight or obese adults has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Non-diabetic Overweight or Obese | Phase 1 | Status: COMPLETED